Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Neurosci Lett ; 594: 163-8, 2015 May 06.
Article in English | MEDLINE | ID: mdl-25697597

ABSTRACT

Fabry disease is an X-linked lysosomal storage disorder characterised by accumulation of glycosphingolipids, and accompanied by clinical manifestations, such as cardiac disorders, renal failure, pain and peripheral neuropathy. Globotriaosylsphingosine (lyso-Gb3), a deacylated form of globotriaosylceramide (Gb3), has emerged as a marker of Fabry disease. We investigated the link between Gb3, lyso-Gb3 and pain. Plantar administration of lyso-Gb3 or Gb3 caused mechanical allodynia in healthy mice. In vitro application of 100nM lyso-Gb3 caused uptake of extracellular calcium in 10% of sensory neurons expressing nociceptor markers, rising to 40% of neurons at 1µM, a concentration that may occur in Fabry disease patients. Peak current densities of voltage-dependent Ca(2+) channels were substantially enhanced by application of 1µM lyso-Gb3. These studies suggest a direct role for lyso-Gb3 in the sensitisation of peripheral nociceptive neurons that may provide an opportunity for therapeutic intervention in the treatment of Fabry disease-associated pain.


Subject(s)
Calcium Channels/physiology , Fabry Disease/metabolism , Glycolipids/pharmacology , Nociceptors/drug effects , Pain/metabolism , Sphingolipids/pharmacology , Animals , Calcium/metabolism , Cells, Cultured , Fabry Disease/physiopathology , Ganglia, Spinal/cytology , Glycolipids/metabolism , Hyperalgesia/metabolism , Hyperalgesia/physiopathology , Mice, Inbred C57BL , Nociceptors/physiology , Pain/physiopathology , Physical Stimulation , Sphingolipids/metabolism , Touch , Trihexosylceramides/metabolism , Trihexosylceramides/pharmacology
2.
Nat Commun ; 4: 1682, 2013.
Article in English | MEDLINE | ID: mdl-23575686

ABSTRACT

Aberrant mechanosensation has an important role in different pain states. Here we show that Epac1 (cyclic AMP sensor) potentiation of Piezo2-mediated mechanotransduction contributes to mechanical allodynia. Dorsal root ganglia Epac1 mRNA levels increase during neuropathic pain, and nerve damage-induced allodynia is reduced in Epac1-/- mice. The Epac-selective cAMP analogue 8-pCPT sensitizes mechanically evoked currents in sensory neurons. Human Piezo2 produces large mechanically gated currents that are enhanced by the activation of the cAMP-sensor Epac1 or cytosolic calcium but are unaffected by protein kinase C or protein kinase A and depend on the integrity of the cytoskeleton. In vivo, 8-pCPT induces long-lasting allodynia that is prevented by the knockdown of Epac1 and attenuated by mouse Piezo2 knockdown. Piezo2 knockdown also enhanced thresholds for light touch. Finally, 8-pCPT sensitizes responses to innocuous mechanical stimuli without changing the electrical excitability of sensory fibres. These data indicate that the Epac1-Piezo2 axis has a role in the development of mechanical allodynia during neuropathic pain.


Subject(s)
Guanine Nucleotide Exchange Factors/physiology , Hyperalgesia/etiology , Ion Channels/physiology , Animals , Base Sequence , Cells, Cultured , Guanine Nucleotide Exchange Factors/metabolism , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Oligodeoxyribonucleotides , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL